85 related articles for article (PubMed ID: 25262704)
21. Drastic elevation of serum CA125, CA72-4 and CA19-9 levels during menses in a patient with probable endometriosis.
Imai A; Horibe S; Takagi A; Takagi H; Tamaya T
Eur J Obstet Gynecol Reprod Biol; 1998 May; 78(1):79-81. PubMed ID: 9605454
[TBL] [Abstract][Full Text] [Related]
22. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer.
Yang XQ; Chen C; Wang FB; Peng CW; Li Y
Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276
[TBL] [Abstract][Full Text] [Related]
23. Predictive value of serum CEA, CA19-9 and CA125 in diagnosis of colorectal liver metastasis in Chinese population.
Zhang D; Yu M; Xu T; Xiong B
Hepatogastroenterology; 2013 Sep; 60(126):1297-301. PubMed ID: 23933921
[TBL] [Abstract][Full Text] [Related]
24. [Effect of compound ezhu powder on serum levels of CA125 and CA19-9, and the expression of cyclin D protein in endometriosis patients].
Wei M; Cao BL; Liu Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Aug; 34(8):926-30. PubMed ID: 25223174
[TBL] [Abstract][Full Text] [Related]
25. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
Lai IR; Lee WJ; Huang MT; Lin HH
Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of CA19-9 versus CA125 for the diagnosis of endometriosis.
Harada T; Kubota T; Aso T
Fertil Steril; 2002 Oct; 78(4):733-9. PubMed ID: 12372448
[TBL] [Abstract][Full Text] [Related]
27. Effect of freeze-thaw cycles on serum measurements of AFP, CEA, CA125 and CA19-9.
Gao YC; Yuan ZB; Yang YD; Lu HK
Scand J Clin Lab Invest; 2007; 67(7):741-7. PubMed ID: 17852813
[TBL] [Abstract][Full Text] [Related]
28. Comparison of clinical usefulness of serum Ca125 and CA19-9 in pancreatic adenocarcinoma diagnosis: meta-analysis and systematic review of literature.
Skulimowski A; Durczyński A; Strzelczyk J; Hogendorf P
Biomarkers; 2021 Jun; 26(4):287-295. PubMed ID: 33459070
[TBL] [Abstract][Full Text] [Related]
29. Analysis of Cerebrospinal Fluid Carbohydrate Antigen Series Biomarkers in Non-neoplastic Diseases.
Shi Q; Tian C; Huang X; Pu C
Ann Clin Lab Sci; 2015; 45(6):623-6. PubMed ID: 26663790
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary sequestration presenting elevated CA19-9 and CA125 with ovarian cysts.
Komatsu H; Mizuguchi S; Izumi N; Inoue H; Oka H; Suehiro S; Nishiyama N
Ann Thorac Cardiovasc Surg; 2014; 20 Suppl():686-8. PubMed ID: 24583704
[TBL] [Abstract][Full Text] [Related]
31. Use of cancer antigen 125, cancer antigen 19-9, and the neutrophil-to-lymphocyte ratio to diagnose mature cystic teratoma with torsion.
Wang YQ; Xia WT; Wang F; Zhuang XX; Zheng FY; Lin F
Int J Gynaecol Obstet; 2017 Jun; 137(3):332-337. PubMed ID: 28273351
[TBL] [Abstract][Full Text] [Related]
32. Elevated serum CA125 and CA19-9 due to the spontaneous rupture of ovarian endometrioma.
Kurata H; Sasaki M; Kase H; Yamamoto Y; Aoki Y; Tanaka K
Eur J Obstet Gynecol Reprod Biol; 2002 Oct; 105(1):75-6. PubMed ID: 12270571
[TBL] [Abstract][Full Text] [Related]
33. Multiple epithelial cysts of the spleen and on the splenic capsule, and high serum levels of CA19-9, CA125 and soluble IL-2 receptor.
Hashimoto T; Sugino T; Fukuda T; Hoshi N; Ogura G; Watanabe K; Satoh Y; Hasegawa T; Ohishi A; Haga J; Miyata M; Suzuki T
Pathol Int; 2004 May; 54(5):349-54. PubMed ID: 15086840
[TBL] [Abstract][Full Text] [Related]
34. Serum tumour markers in patients with chronic kidney disease.
Xiaofang Y; Yue Z; Xialian X; Zhibin Y
Scand J Clin Lab Invest; 2007; 67(6):661-7. PubMed ID: 17852811
[TBL] [Abstract][Full Text] [Related]
35. Application of C12 multi-tumor marker protein chip in the diagnosis of gastrointestinal cancer: results of 329 surgical patients and suggestions for improvement.
Yang XQ; Yan L; Chen C; Hou JX; Li Y
Hepatogastroenterology; 2009; 56(94-95):1388-94. PubMed ID: 19950797
[TBL] [Abstract][Full Text] [Related]
36. A case of malignant lymphoma in a patient with high levels of CA125 and CA19-9.
Kajiume T; Yoshimi S; Kobayashi K; Kataoka N
Pediatr Hematol Oncol; 2000; 17(3):269-72. PubMed ID: 10779994
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy.
Huo YR; Huang Y; Liauw W; Zhao J; Morris DL
Anticancer Res; 2016 Mar; 36(3):1041-9. PubMed ID: 26976996
[TBL] [Abstract][Full Text] [Related]
38. [Ovarian tumor markers of presumed benign ovarian tumors].
Lahlou N; Brun JL
J Gynecol Obstet Biol Reprod (Paris); 2013 Dec; 42(8):752-9. PubMed ID: 24210243
[TBL] [Abstract][Full Text] [Related]
39. CA19-9 elevation in ovarian mature cystic teratoma: discrimination from ovarian cancer - CA19-9 level in teratoma.
Cho HY; Kim K; Jeon YT; Kim YB; No JH
Med Sci Monit; 2013 Mar; 19():230-5. PubMed ID: 23539074
[TBL] [Abstract][Full Text] [Related]
40. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
